Zai Lab (ZLAB) Other Operating Expenses (2023)

Zai Lab (ZLAB) posted Other Operating Expenses of $10.0 million for Q2 2023.

Zai Lab (ZLAB) Other Operating Expenses (2023) Analysis & Trends

Zai Lab has reported Other Operating Expenses for 1 years, with the latest figure at $10.0 million in Q2 2023.

Quarterly Other Operating Expenses changed N/A year-over-year to $10.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $10.0 million (changed N/A YoY) and the FY2023 annual result came in at $10.0 million, changed N/A from the prior year.
Other Operating Expenses held at $10.0 million in Q2 2023 per ZLAB's latest filing.
Over five years, Other Operating Expenses peaked at $10.0 million in Q2 2023 and troughed at $10.0 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Zai Lab	2.91 Bn	2.20 Bn	58.15 Mn

Download Data

Date	Value
Jun 30, 2023	10.00 Mn